Transdifferentiation of human endothelial progenitors into smooth muscle cells

Biomaterials

Volumn 85, Issue , 2016, Pages 180-194

  Ji, HaYeun ^a   Atchison, Leigh ^b   Chen, Zaozao ^a   Chakraborty, Syandan ^a   Jung, Youngmee ^d   Truskey, George A ^b   Christoforou, Nicolas ^b,c   Leong, Kam W ^a  

^a Department of Earth and Environmental Sciences   (United States)

^b Duke University   (United States)

^c KHALIFA UNIVERSITY   (United Arab Emirates)

^d Korea Institute of Science and Technology   (South Korea)

Author keywords

Direct reprogramming; Direct transdifferentiation; Myocardin; Smooth muscle cell differentiation; Tissue engineered blood vessel

Indexed keywords

BLOOD VESSEL PROSTHESES; CELL ENGINEERING; CELLS; CYTOLOGY; ENDOTHELIAL CELLS; GENE EXPRESSION; MUSCLE; TISSUE; TISSUE ENGINEERING; TRACTION CONTROL;

DIRECT REPROGRAMMING; MYOCARDIN; SMOOTH MUSCLE CELL DIFFERENTIATION; TISSUE ENGINEERED BLOOD VESSELS; TRANS DIFFERENTIATIONS;

BLOOD VESSELS;

MUSCLE MYOSIN HEAVY CHAIN 11; MYOCARDIN; MYOSIN HEAVY CHAIN; PHENYLEPHRINE; TRANSGELIN; UNCLASSIFIED DRUG; ACTA2 PROTEIN, HUMAN; ACTIN; ACTIN BINDING PROTEIN; CADHERIN; CD31 ANTIGEN; ENDOGLIN; ENG PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MUSCLE PROTEIN; MYH11 PROTEIN, HUMAN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; CALCIUM SIGNALING; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; CYTOSKELETON; ENDOTHELIAL PROGENITOR CELL; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; MESENCHYME CELL; MICROARRAY ANALYSIS; NUCLEAR REPROGRAMMING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION; CYTOLOGY; DOWN REGULATION; GENE TRANSFER; GENETICS; METABOLISM; SMOOTH MUSCLE CELL; TISSUE ENGINEERING;

ACTINS; ANTIGENS, CD; ANTIGENS, CD31; CADHERINS; CELL TRANSDIFFERENTIATION; DOWN-REGULATION; ENDOGLIN; ENDOTHELIAL PROGENITOR CELLS; GENE TRANSFER TECHNIQUES; HUMANS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; MYOCYTES, SMOOTH MUSCLE; MYOSIN HEAVY CHAINS; NUCLEAR PROTEINS; TISSUE ENGINEERING; TRANS-ACTIVATORS; UP-REGULATION;

EID: 84958212615     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2016.01.066     Document Type: Article

References (63)

1. de Mel A., et al. A potential platform for developing 3D tubular scaffolds for paediatric organ development. J. Mater. Sci. Mater. Med. 2015, 26:141. 10.1007/s10856-015-5477-4.
2. Ha J.M., et al. Platelet-derived growth factor regulates vascular smooth muscle phenotype via mammalian target of rapamycin complex 1. Biochem. Biophys. Res. Commun. 2015, 10.1016/j.bbrc.2015.05.097.
3. Owens G.K., Kumar M.S., Wamhoff B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 2004, 84:767-801. 10.1152/physrev.00041.2003.
4. Li S., Sims S., Jiao Y., Chow L.H., Pickering J.G. Evidence from a novel human cell clone that adult vascular smooth muscle cells can convert reversibly between noncontractile and contractile phenotypes. Circ. Res. 1999, 85:338-348.
5. Somlyo A.P., Somlyo A.V. Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol. Rev. 2003, 83:1325-1358. 10.1152/physrev.00023.2003.
6. Alexander M.R., Owens G.K. Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu. Rev. Physiol. 2012, 74:13-40. 10.1146/annurev-physiol-012110-142315.
7. Chistiakov D.A., Orekhov A.N., Bobryshev Y.V. Vascular smooth muscle cell in atherosclerosis. Acta Physiol. (Oxf) 2015, 214:33-50. 10.1111/apha.12466.
8. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. Physiol. Rev. 1995, 75:487-517.
9. Wang Z., Wang D.Z., Pipes G.C., Olson E.N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:7129-7134. 10.1073/pnas.1232341100.
10. Hedin U., Bottger B.A., Luthman J., Johansson S., Thyberg J. A substrate of the cell-attachment sequence of fibronectin (Arg-Gly-Asp-Ser) is sufficient to promote transition of arterial smooth muscle cells from a contractile to a synthetic phenotype. Dev. Biol. 1989, 133:489-501.
11. Wang Y., et al. Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds. Biomaterials 2014, 35:8960-8969. 10.1016/j.biomaterials.2014.07.011.
12. Bajpai V.K., Mistriotis P., Loh Y.H., Daley G.Q., Andreadis S.T. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc. Res. 2012, 96:391-400. 10.1093/cvr/cvs253.
13. Vierbuchen T., et al. Direct conversion of fibroblasts to functional neurons by defined factors. Nature 2010, 463:1035-1041. 10.1038/nature08797.
14. Adler A.F., et al. Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells. Mol. Ther. Nucleic Acids 2012, 1:e32. 10.1038/mtna.2012.25.
15. Chanda S., et al. Generation of induced neuronal cells by the single reprogramming factor ASCL1. Stem Cell Rep. 2014, 3:282-296. 10.1016/j.stemcr.2014.05.020.
16. Rafii S., Lyden D. Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 2003, 9:702-712. 10.1038/nm0603-702.
17. Ingram D.A., et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 2004, 104:2752-2760. 10.1182/blood-2004-04-1396.
18. Pipes G.C., Creemers E.E., Olson E.N. The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev. 2006, 20:1545-1556. 10.1101/gad.1428006.
19. Chen J., Kitchen C.M., Streb J.W., Miano J.M. Myocardin: a component of a molecular switch for smooth muscle differentiation. J. Mol. Cell Cardiol. 2002, 34:1345-1356.
20. Miano J.M. Myocardin in biology and disease. J. Biomed. Res. 2015, 29:3-19. 10.7555/JBR.29.20140151.
21. Li S., Wang D.Z., Wang Z., Richardson J.A., Olson E.N. The serum response factor coactivator myocardin is required for vascular smooth muscle development. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:9366-9370. 10.1073/pnas.1233635100.
22. Long X.C., Bell R.D., Gerthoffer W.T., Zlokovic B.V., Miano J.M. Myocardin is sufficient for a smooth muscle-like contractile phenotype. Arter. Thromb. Vasc. 2008, 28:1505-1510. 10.1161/ATVBAHA.108.166066.
23. Du K.L., et al. Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation. Mol. Cell Biol. 2003, 23:2425-2437.
24. Kristensen J.M., et al. A PGC-1alpha- and muscle fibre type-related decrease in markers of mitochondrial oxidative metabolism in skeletal muscle of humans with inherited insulin resistance. Diabetologia 2014, 57:1006-1015. 10.1007/s00125-014-3187-y.
25. Smith L.R., Chambers H.G., Subramaniam S., Lieber R.L. Transcriptional abnormalities of hamstring muscle contractures in children with cerebral palsy. PLoS One 2012, 7:e40686. 10.1371/journal.pone.0040686.
26. Pine P.S., Rosenzweig B.A., Thompson K.L. An adaptable method using human mixed tissue ratiometric controls for benchmarking performance on gene expression microarrays in clinical laboratories. BMC Biotechnol. 2011, 11:38. 10.1186/1472-6750-11-38.
27. Wessells H., et al. Transcriptional profiling of human cavernosal endothelial cells reveals distinctive cell adhesion phenotype and role for claudin 11 in vascular barrier function. Physiol. Genom. 2009, 39:100-108. 10.1152/physiolgenomics.90354.2008.
28. Greene C.S., et al. Understanding multicellular function and disease with human tissue-specific networks. Nat. Genet. 2015, 47:569-576. 10.1038/ng.3259.
29. Olesen M., Skov V., Mechta M., Mumm B.H., Rasmussen L.M. No influence of OPG and its ligands, RANKL and TRAIL, on proliferation and regulation of the calcification process in primary human vascular smooth muscle cells. Mol. Cell. Endocrinol. 2012, 362:149-156. 10.1016/j.mce.2012.06.004.
30. Wang X.M., et al. The gene expression profiles of induced pluripotent stem cells from individuals with childhood cerebral adrenoleukodystrophy are consistent with proposed mechanisms of pathogenesis. Stem Cell Res. Ther. 2012, 3:39. 10.1186/scrt130.
31. Roider H.G., Manke T., O'Keeffe S., Vingron M., Haas S.A. PASTAA: identifying transcription factors associated with sets of co-regulated genes. Bioinformatics 2009, 25:435-442. 10.1093/bioinformatics/btn627.
32. Zhao Y., et al. An expanded palette of genetically encoded Ca(2)(+) indicators. Science 2011, 333:1888-1891. 10.1126/science.1208592.
33. Ratz P.H., Berg K.M., Urban N.H., Miner A.S. Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. Am. J. Physiol. Cell Physiol. 2005, 288:C769-C783. 10.1152/ajpcell.00529.2004.
34. Collins E.M., Walsh M.P., Morgan K.G. Contraction of single vascular smooth muscle cells by phenylephrine at constant [Ca2+]i. Am. J. Physiol. 1992, 262:H754-H762.
35. Maskarinec S.A., Franck C., Tirrell D.A., Ravichandran G. Quantifying cellular traction forces in three dimensions. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:22108-22113. 10.1073/pnas.0904565106.
36. Ye G.J., et al. The contractile strength of vascular smooth muscle myocytes is shape dependent. Integr. Biol. (Camb) 2014, 6:152-163. 10.1039/c3ib40230d.
37. Lee T.H., et al. Functional recapitulation of smooth muscle cells via induced pluripotent stem cells from human aortic smooth muscle cells. Circ. Res. 2010, 106:120-128. 10.1161/CIRCRESAHA.109.207902.
38. Cheung C., Bernardo A.S., Trotter M.W., Pedersen R.A., Sinha S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat. Biotechnol. 2012, 30:165-173. 10.1038/nbt.2107.
39. Wang D., et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001, 105:851-862.
40. Raphel L., Talasila A., Cheung C., Sinha S. Myocardin overexpression is sufficient for promoting the development of a mature smooth muscle cell-like phenotype from human embryonic stem cells. PLoS One 2012, 7:e44052. 10.1371/journal.pone.0044052.
41. Earley S., Brayden J.E. Transient receptor potential channels in the vasculature. Physiol. Rev. 2015, 95:645-690. 10.1152/physrev.00026.2014.
42. Utz J., Eckert R., Trautwein W. Changes of intracellular calcium concentrations by phenylephrine in renal arterial smooth muscle cells. Pflugers Arch. 1999, 438:725-731.
43. Hamada H., Damron D.S., Hong S.J., Van Wagoner D.R., Murray P.A. Phenylephrine-induced Ca2+ oscillations in canine pulmonary artery smooth muscle cells. Circ. Res. 1997, 81:812-823.
44. Dora K.A., Doyle M.P., Duling B.R. Elevation of intracellular calcium in smooth muscle causes endothelial cell generation of NO in arterioles. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:6529-6534.
45. Wang J.H., Lin J.S. Cell traction force and measurement methods. Biomech. Model Mechanobiol. 2007, 6:361-371. 10.1007/s10237-006-0068-4.
46. Chen J., Li H., SundarRaj N., Wang J.H. Alpha-smooth muscle actin expression enhances cell traction force. Cell Motil. Cytoskelet. 2007, 64:248-257. 10.1002/cm.20178.
47. Sinha S., et al. Assessment of contractility of purified smooth muscle cells derived from embryonic stem cells. Stem Cells 2006, 24:1678-1688. 10.1634/stemcells.2006-0002.
48. Dora K.A., Hinton J.M., Walker S.D., Garland C.J. An indirect influence of phenylephrine on the release of endothelium-derived vasodilators in rat small mesenteric artery. Br. J. Pharmacol. 2000, 129:381-387. 10.1038/sj.bjp.0703052.
49. L'Heureux N., et al. Human tissue-engineered blood vessels for adult arterial revascularization. Nat. Med. 2006, 12:361-365. 10.1038/nm1364.
50. Gong Z., Niklason L.E. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J. 2008, 22:1635-1648. 10.1096/fj.07-087924.
51. Weinberg C.B., Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science 1986, 231:397-400.
52. Jung Y., et al. Scaffold-free, human mesenchymal stem cell-based tissue engineered blood vessels. Sci. Rep. 2015, 5:15116. 10.1038/srep15116.
53. Truskey G.A., Fernandez C.E. Tissue-engineered blood vessels as promising tools for testing drug toxicity. Expert Opin. Drug Metab. Toxicol. 2015, 1-4. 10.1517/17425255.2015.1047342.
54. Rajendran P., et al. The vascular endothelium and human diseases. Int. J. Biol. Sci. 2013, 9:1057-1069. 10.7150/ijbs.7502.
55. Brown M.A., Wallace C.S., Angelos M., Truskey G.A. Characterization of umbilical cord blood-derived late outgrowth endothelial progenitor cells exposed to laminar shear stress. Tissue Eng. Part A 2009, 15:3575-3587. 10.1089/ten.TEA.2008.0444.
56. Christoforou N., et al. Transcription factors MYOCD, SRF, Mesp1 and SMARCD3 enhance the cardio-inducing effect of GATA4, TBX5, and MEF2C during direct cellular reprogramming. PLoS One 2013, 8:e63577. 10.1371/journal.pone.0063577.
57. Maherali N., et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 2008, 3:340-345. 10.1016/j.stem.2008.08.003.
58. Zhang B., Kirov S., Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res. 2005, 33:W741-W748. 10.1093/nar/gki475.
59. Warde-Farley D., et al. The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res. 2010, 38:W214-W220. 10.1093/nar/gkq537.
60. Butler J.P., Tolic-Norrelykke I.M., Fabry B., Fredberg J.J. Traction fields, moments, and strain energy that cells exert on their surroundings. Am. J. Physiol. Cell Physiol. 2002, 282:C595-C605. 10.1152/ajpcell.00270.2001.
61. Trepat X., et al. Physical forces during collective cell migration. Nat. Phys. 2009, 5:426-430. doi. http://www.nature.com/nphys/journal/v5/n6/suppinfo/nphys1269_S1.html.
62. Ghezzi C.E., et al. An airway smooth muscle cell niche under physiological pulsatile flow culture using a tubular dense collagen construct. Biomaterials 2013, 34:1954-1966. 10.1016/j.biomaterials.2012.11.025.
63. Phillips J.B., Brown R. Micro-structured materials and mechanical cues in 3D collagen gels. Methods Mol. Biol. 2011, 695:183-196. 10.1007/978-1-60761-984-0_12.